A Comprehensive Survey on Super-Resolution Techniques in Medical Imaging
December 15, 2025
No Comments
Read More »
*Corresponding Author: S Apoorva, Post graduate student from Department of Periodontics, St Joseph Dental College and Hospital, India
Aim: To compare the effectiveness of Noni and Bilberry in treating chronic periodontitis.
Materials and methods: The current study is a double-masked, randomized clinical trial. A total of forty patients of age 20 to 55 years were assigned randomly into two groups. After phase-I therapy, In Group A, Morinda citrifolia (MC) (Noni – 1000 mg, Biotrex company) and in Group B, Vaccinium myrtillus L (Bilberry – Biotrex)– 275mg was given adjunctively. In both groups, gingival index (GI), plaque index (PI), clinical parameters such as periodontal probing depth (PPD) and clinical attachment level (CAL), and bone biomarker C-terminal telopeptide (serum β-CTX) were evaluated at baseline and after six months.
Results: The results of the current trial showed that all subjects from the two groups had a significant decrease in the GI, PI, and clinical parameters like PPD and CAL compared from baseline to three months. There was a significant reduction in serum β-CTX levels after phase I therapy in chronic periodontitis subjects after host modulation with Noni and Bilberry. In both the groups, a positive correlation was shown between the clinical parameters and serum c levels. However, there was a statistically significant decrease in the serum β-CTX levels in the group treated with noni compared with the bilberry group.
Conclusion: Morinda citrifolia (Noni) had shown significant effect compared to Vaccinium myrtillus L(bilberry) in treating chronic periodontitis. The beneficial effect of noni is most probably a result of its well-known anti-inflammatory activity.
